Ross Bullock Selected Research

Initiator Caspases

1/2020

EphB3 interacts with initiator caspases and FHL-2 to activate dependence receptor cell death in oligodendrocytes after brain injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ross Bullock Research Topics

Disease

9	Traumatic Brain Injuries (Traumatic Brain Injury) 09/2013 - 05/2003
7	Brain Injuries (Brain Injury) 01/2020 - 08/2005
4	Hemorrhage 09/2015 - 03/2004
4	Hypothermia 01/2013 - 03/2002
4	Craniocerebral Trauma (Head Injury) 03/2011 - 03/2002
2	Wounds and Injuries (Trauma) 10/2017 - 08/2004
2	Subdural Hematoma (Subdural Hemorrhage) 01/2013 - 09/2002
2	Stroke (Strokes) 08/2012 - 06/2003
2	Hypoxia (Hypoxemia) 08/2005 - 09/2002
2	Edema (Dropsy) 06/2003 - 05/2003
1	Carcinogenesis 01/2022
1	Sinusitis 08/2016
1	Cerebral Hemorrhage 09/2015
1	Reperfusion Injury 01/2013
1	Radiculopathy (Radiculopathy, Cervical) 01/2011
1	Bacterial Endocarditis 01/2011
1	Seizures (Absence Seizure) 09/2008
1	Mitochondrial Diseases (Mitochondrial Disease) 04/2006
1	Diffuse Brain Injuries (Diffuse Brain Injury) 08/2004
1	Thrombosis (Thrombus) 03/2004
1	Ischemia 06/2003
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 06/2003
1	Brain Hypoxia (Cerebral Hypoxia) 09/2002
1	Skull Fractures (Skull Fracture) 04/2002

Drug/Important Bio-Agent (IBA)

5	Lactic Acid (Lactate)FDA LinkGeneric 01/2005 - 03/2002
4	Biomarkers (Surrogate Marker)IBA 10/2017 - 06/2003
4	Oxygen (Dioxygen)IBA 01/2006 - 03/2002
4	Glucose (Dextrose)FDA LinkGeneric 01/2005 - 09/2002
3	Neuroprotective AgentsIBA 09/2013 - 05/2003
3	Glutamic Acid (Glutamate)FDA Link 01/2005 - 03/2002
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 09/2013 - 01/2006
2	Pharmaceutical PreparationsIBA 04/2006 - 05/2003
2	salicylhydroxamic acid (SHAM)IBA 08/2004 - 04/2002
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2022
1	Hematoxylin (Haematoxylon)IBA 01/2022
1	Death Domain ReceptorsIBA 01/2020
1	Initiator CaspasesIBA 01/2020
1	LigandsIBA 01/2020
1	PhosphoproteinsIBA 10/2017
1	Fatty Acid-Binding Protein 7IBA 10/2017
1	Fructose-Bisphosphate Aldolase (Aldolase)IBA 10/2017
1	Proteins (Proteins, Gene)FDA Link 10/2017
1	ProteomeIBA 10/2017
1	Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA 10/2017
1	Vancomycin FDA LinkGeneric 08/2016
1	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 08/2016
1	Cytidine Triphosphate (CTP)IBA 09/2015
1	Tissue Plasminogen Activator (Alteplase)FDA Link 09/2015
1	Dialysis SolutionsIBA 09/2013
1	Analgesics (Analgesic Drugs)IBA 08/2012
1	Hypnotics and Sedatives (Sedatives)IBA 08/2012
1	Ketamine FDA LinkGeneric 08/2012
1	Glial Fibrillary Acidic ProteinIBA 04/2012
1	Ubiquitin Thiolesterase (Ubiquitin Carboxy-Terminal Hydrolase)IBA 04/2012
1	Indicators and Reagents (Reagents)IBA 04/2012
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2009
1	Mitochondrial Permeability Transition PoreIBA 04/2006
1	CalciumIBA 04/2006
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2006
1	Topiramate (Topamax)FDA LinkGeneric 01/2006
1	Glycerol (Glycerine)FDA LinkGeneric 08/2005
1	Pyruvic Acid (Pyruvate)IBA 01/2005
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 03/2004
1	SolutionsIBA 03/2004
1	Saline SolutionIBA 03/2004
1	Excitatory Amino Acid AntagonistsIBA 06/2003
1	Ion Channels (Ion Channel)IBA 06/2003
1	N-Methylaspartate (NMDA)IBA 06/2003
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 06/2003
1	AcidsIBA 09/2002

Therapy/Procedure

6	Therapeutics 08/2013 - 08/2004
3	Induced Hypothermia 01/2013 - 05/2002
1	Minimally Invasive Surgical Procedures 09/2015
1	Craniotomy 01/2013
1	Decompression 01/2013
1	Decompressive Craniectomy 03/2011
1	Pain Management 01/2011
1	Electrodes (Electrode) 09/2008
1	Ventriculostomy 03/2004
1	Intraventricular Injections 03/2004